We sought to identify changes in platelet (PLT) counts over time, and to evaluate the patterns of thrombocytopenia and thrombocytosis in hospitalized infants 23.8 weeks to term gestation.
INTRODUCTION
Regulation of thrombopoiesis is affected by age. When compared to adults, neonates have smaller, lower ploidy megakaryocytes, with a reduced rate of platelet (PLT) production. [1] [2] [3] [4] However, since PLT counts from the cord blood of fetuses and newborns fall within the normal adult range, the hypothesis that fetal megakaryocyte progenitors have a higher proliferative rate has been proposed, 5 and some in vitro evidence indicates that enhanced sensitivity of neonatal megakaryocytes to cytokines may be involved. 6 Despite this, thrombocytopenia occurs commonly in neonatal intensive care units (NICUs). 7 Thrombocytopenia, defined as a PLT count of <150,000/ml, has been recognized in up to 25% of neonates. 7 Thrombocytopenia can result from increased PLT utilization or decreased thrombopoiesis. Neonatal conditions associated with thrombocytopenia include congenital or acquired viral infection (e.g. rubella, herpes, cytomegalovirus, HIV), fungal or bacterial sepsis, necrotizing enterocolitis (NEC), mechanical ventilation, hyperviscosity, alloimmune thrombocytopenia, and maternal drug exposure (e.g. cimetidine). [8] [9] [10] Severe thrombocytopenia may be associated with increased risk of hemorrhage, and increased mortality. [11] [12] [13] Thrombocytosis, defined here as a PLT count of >500,000/ml, has been estimated to occur in 1 to 13% of children, usually in the first year of life. 14, 15 Although secondary thrombocytosis can be associated with thrombosis, myocardial infarction, and thrombohemorrhagic complications in adults and infants, in neonates it is often neglected as a benign indicator of other conditions. 16, 17 These conditions include sepsis, respiratory tract infection, anemia, stress, iron deficiency, hemorrhage, drug exposure (e.g. epinephrine), vitamin E deficiency, and rebound from thrombocytopenia. 14, 18, 19 The improved survival of extremely low birth weight infants has enabled a comparative analysis of PLT counts from a broader range of gestational ages than was previously available. In this report, we characterize the time course of PLT counts from preterm infants ranging from 23.8 weeks to term gestation. In addition, we examine the impact of anemia, infection, and maternal pregnancy-induced hypertension (PIH) on neonatal PLT counts.
MATERIALS AND METHODS
Infants at the University of Washington (UW) NICU underwent routine weekly complete blood counts (CBCs). Data from additional CBCs were recorded when available. Data were collected from NICU in-patients between February 1, 2001 and March 31, 2002.
Gestational age, birth weight, Apgar scores, and infant diagnoses were recorded. Infant conditions included: electrolyte imbalance, apnea of prematurity, respiratory distress syndrome, chronic lung disease, pulmonary interstitial emphysema, pneumatocele, pneumonia, hypotension, patent ductus arteriosus, congenital heart defect, hyperbilirubinemia, cholestasis, NEC, anemia, intracranial hemorrhage, osteopenia, hypoparathyroidism, rotavirus, and sepsis. Maternal diagnoses included intra-amniotic infection and PIH. Gestational age was determined respectively in order of preference: first trimester ultrasound or in vitro fertilization, later prenatal ultrasound, last menstrual period, or estimation by a neonatologist. Data were grouped according to weeks of gestation completed at birth as follows: less than 27 weeks (<27), 27 to 29.9 weeks (27<30), 30 to 34.9 weeks (30<35), and 35 weeks or older (35 þ ). 20 The UW Institutional Review approved the use of these data.
CBCs were performed on blood samples collected in EDTA tubes, and hematocrit (HCT) and PLT counts were determined by flow cytometry in the UW Laboratory Medicine Department using the Abbott CellDyn 3500 (Chicago, IL).
Statistical evaluation of PLT counts was performed. Descriptive statistics, a combined frequency distribution, and separate frequency distributions were prepared for each age group. For repeated measures analysis, nonparametric generalized means estimation was conducted by a professional consultant using Stata (College Station, TX). All other statistics were obtained using SPSS (Chicago, IL).
A mean weekly PLT count was calculated so that each subject was represented by a single score/week. Mean weekly PLT counts were analyzed by repeated measures using age and time, or age and time and diagnosis as factors. Dunnett's test was used to compare multiple events back to a single event. Tukey's tests with Kramer correction were used to compare independent groups. To further reduce false positives, comparisons were restricted. Data are presented as mean±standard deviation (SD) or standard error of the mean (SEM) as indicated.
Effects of age on prevalence rates were evaluated by w 2 . Effects of anemia were examined by ANOVA of CBCs in which both a HCT and PLT count were measured with anemia indicated by a HCT cutoff of <28%. Two conditions, small for gestational age (SGA, n ¼ 94) and maternal PIH (n ¼ 87) were 95% coincident and collapsed together. Presumed infections occurred when the patient was symptomatic, treated with a full course of antibiotics, but cultures were negative. Documented infections were culture proven (positive blood or spinal fluid culture), and effects were examined by ANOVA using CBCs in which a PLT count was made within 1 week (À2 or þ 5 days) of diagnosis. 10 Infants were considered noninfected outside this interval. Infants with NEC were evaluated separately. Infants with NEC that required surgery were sent to an affiliated center and only mortality was followed after transfer. Effects of non-life-threatening infections (e.g. tracheitis, conjunctivitis, and urinary tract infection) were not considered.
RESULTS
Our overall analysis included 1498 CBCs with PLT counts available from 341 infants. Figure 1 is a box and whisker plot of all PLT counts collected from noninfected, non-PIH-exposed, sizeappropriate for gestational age (AGA) infants separated by age group. Note that PLT count variability is large in the preterm infants, and narrows with increasing postconceptional age. A corresponding frequency distribution of all PLT counts from noninfected, AGA infants is inset in Figure 1 . The inset shows that the distribution of the combined PLT counts from all groups is positively skewed ( pr0.001) with 76.8% of counts within the normal range (150 to 500,000/ml), 11.0% in the thrombocytopenic range (<150,000/ml), and 12.2% in the thrombocytotic range (>500,000/ml). Figure 1 . Distribution of PLT counts from hospitalized neonates. Box and whisker plot showing the distribution of PLT counts from groups of noninfected, non-PIH-exposed NICU infants (n ¼ 237) separated by gestational age at birth. Counts obtained within a week of any diagnosed infection were not included. Box plots show the mean (±SEM), median (center line), the 25 and 75% quartiles (box), with whiskers indicating the range of values. Extreme outliers beyond three quartiles were all high values and were omitted. The number of PLT counts is indicated along the X-axis. ANOVA followed by Dunnett's test found that mean PLT counts at 35 þ weeks are lower than each other group (*pr0.05). The inset shows the positively skewed ( pr0.001) frequency distribution histogram of 830 combined PLT counts in bin increments of 50. Of those counts, 11.0% were thrombocytopenic, 76.8% were normal (dotted box), and 12.2% were thrombocytotic. Note that this figure includes all PLT counts, including those that fall outside the normal range of 150 to 500,000/ml. Table 1 includes demographic information from 341 AGA and PIH/SGA infants separated by gestational age groups. The incidence rates of thrombocytopenia and thrombocytosis for all infants (includes infections) and noninfected infants are shown. Abnormal PLT counts were present in every age group in both AGA and SGA infants. The effects of sepsis on the incidence of abnormal PLT counts vary depending on age group and PIH exposure. In the absence of infection, the rates of both thrombocytopenia and thrombocytosis differ significantly across age groups and appear to vary inversely with increasing gestational age ( Table 1 ).
The influence of postconceptional age on thrombocytopenia and thrombocytosis was further evaluated by calculating the frequency of abnormal counts and plotting them according to the corrected gestational age (CGA) using counts from noninfected AGA infants. Figure 2 illustrates gestation-dependent patterns for abnormal PLT counts. Thrombocytopenia occurred at earlier gestational ages with a peak frequency at 31 weeks, while thrombocytosis occurred later, peaking at 35 weeks CGA.
Next, we examined the effect of postnatal age on PLTs by contrasting the time course of PLT counts across gestational age groups. Figure 3 shows the mean weekly PLT count for all 338 infants available during the first 4 weeks of life (top panel), and the corresponding risk of thrombocytosis for each age group (bottom panel). Gestational age and time affected PLT counts, and counts increased over time for ages 27<30, 30<35, and 35 þ Effect of postconceptional age on thrombocytopenia and thrombocytosis. This histogram illustrates the influence of postconceptional age on the frequency of thrombocytopenic and thrombocytotic PLT counts. Instances of PLT counts below 150,000/ml (black bar) or greater than 500,000/ml (gray bar) were counted from noninfected AGA infants and grouped according to the CGA at testing. Age significantly altered the rates of prevalence for both thrombocytopenia (w 2 ¼ 52.8, pr0.001), and thrombocytosis (w 2 ¼ 45.3, pr0.001), Thrombocytopenia appears early and is most frequent near 31 weeks, while thrombocytosis appears later and is most frequent around 35 weeks CGA. These patterns may reveal the developmental period during which PLT stability matures.
(all pr0.001). Mean PLT counts from the <27-week age group did not change over the first 4 weeks of life. PLT counts were not different across groups at week 1, but at weeks 2, 3, and 4, the 30<35-week age group had significantly higher counts than other groups (Figure 3 ). Corresponding risk of thrombocytosis was zero in the first week of life, increased weekly, and was greatest in the fourth week of life for infants born at 30<35 weeks (38.1%).
Thrombocytopenia in noninfected infants was next examined by identifying instances of thrombocytopenia each week during the first 12 weeks of neonatal life. Figure 4 is a histogram comparing the thrombocytopenia evident in noninfected AGA (top panel, n ¼ 30) vs noninfected PIH/SGA infants (bottom panel, n ¼ 27). The less mature infants are hospitalized longer and are at risk for thrombocytopenia throughout hospitalization. While 98% of infants in the <27-week group were mechanically ventilated for either respiratory distress or apnea of prematurity (mean duration 31 days), only 40% of the noninfected AGA infants with thrombocytopenia after 5 weeks of life (n ¼ 10) were still intubated. Note that PIH/SGA infants were at higher risk of thrombocytopenia in the first 2 weeks while the AGA group showed a more prolonged risk.
The effect of anemia on PLT counts was evaluated in 125 CBCs with anemia present (HCT <28%). Overall, PLT counts were higher (mean 375,000/ml with anemia vs 281,000/ml, without, pr0.001), but this effect was not consistent. For example, the 30<35-week infants only had six instances of thrombocytosis during 17 instances of anemia. Late thrombocytosis (Figure 3b ) was not associated with anemia, prior thrombocytopenia, PLT transfusion, nor any type of early infection. For some patients, a measure of iron status was available (Zn protoporphyrin/heme), 21 but there were no correlations between PLT counts and iron status.
Although thrombocytopenia was common in noninfected AGA infants (Table 1) , fungal, Gram-negative, Gram-positive, and presumed infections were all associated with a significant decrease in PLT count, and an increased risk of thrombocytopenia. Table 2 lists the incidence of infections, the corresponding frequency of thrombocytopenia, and shows that infection risk varied inversely with increasing gestational age at birth. A total of 14 infants (4%) were diagnosed with NEC at an average CGA of 30.8 weeks (range 26.9 to 34.4 weeks). NEC developed on average 16 days after birth (range 3 to 38 days). Six infants required surgical treatment. The mortality due to NEC was 36%. Both thrombocytopenia and thrombocytosis were evident in NEC infants. When PLT transfusions were required, a pattern of rapid PLT consumption was observed.
Excluding NEC, 31 PLT transfusions were administered to 13 infants. PLT counts obtained during the course of these transfusions were not included in the analysis above. In all 43% of all PLT counts measured from infants who received PLT transfusions were thrombocytopenic. The mean PLT count (±SEM) before transfusion was 53,000±5,000/ml, and after transfusion was 261,000±37,000/ml. The range of counts was 19,000 to 110,000/ml before transfusion, and 85,000 to 966,000/ml after transfusion. Follow-up count requests were determined at the physician's discretion and were generally based upon the speed and severity of the fall in PLT count, and the suspected etiology of the thrombocytopenia. However, of 31 transfusions to 13 infants, 61% of the follow-up counts were within 24 hours of transfusion.
Nine of these infants received two or more PLT transfusions. Two patients died within 2 days following PLT transfusion, both were septic and thrombocytopenic, and both were from the <27-week group.
We further examined the subgroup of infants with severe neonatal thrombocytopenia (PLT count <50,000/ml), as this degree of thrombocytopenia often causes great concern about etiology, treatment, and prognosis. In all, 18 infants had 28 PLT counts below 50,000/ml. Of these infants, 11 had sepsis or NEC (associated organisms included: Enterobacter, Staphylococcus aureus, Staphylococcus epidermitis, Candida albicans, Malassezia pachydermatis), two had presumed congenital infections, three had either twin-twin transfusion, or double volume exchange transfusions, and two were idiopathic. Seven of the 18 infants (39%) were given PLT transfusions.
DISCUSSION
This report is a retrospective evaluation of neonatal PLT counts from infants at a single center with gestational ages ranging from 23.8 weeks to term. To our knowledge, this is the only repeated measures analysis of the time course of PLT counts over the first 4 weeks of life that includes infants <27 weeks gestation. Collectively, the findings suggest that both thrombocytopenia and thrombocytosis are common in noninfected AGA infants and may be best explained as a function of postconceptional age, and thus possibly indicative of the underlying developmental maturation of PLT regulation.
There is a decline in the variability of PLT counts as gestational age increases (Figure 1) . Correspondingly, the overall prevalence of abnormal counts, both high and low, also decreases with maturity (Table 1 and Figure 2) . Thrombocytopenia was more frequent below 34 weeks CGA while thrombocytosis became more frequent at this age (Figure 2 ). For more mature infants, thrombocytopenia appeared early while thrombocytosis appeared later in neonatal life, suggesting an overcompensation by the marrow. In the least mature group of noninfected AGA infants, risk of thrombocytopenia was protracted across the first 12 weeks of life (Figure 4 ). Exposure to PIH was associated with increased risk of thrombocytopenia, which resolved after the first 2 weeks of life. Thrombocytopenia and thrombocytosis were most common in infants born at less than 27 weeks gestation, and neither condition was fully explained by mechanical ventilation, infection, anemia, or PIH (Table 1) .
In agreement with prior findings, [8] [9] [10] presumed, fungal, Gramnegative, and Gram-positive infections all significantly reduced neonatal PLT counts (Table 2b ). In our population, both Gram-positive and Gram-negative infections were associated with lowered PLT counts and a roughly 50% risk of concurrent thrombocytopenia. Fungal infections were associated with the largest decline in PLT count and the highest risk (71%) of thrombocytopenia. These findings are in contrast to the recent analysis in which Gram-negative and fungal infections were associated with a higher incidence and greater duration of thrombocytopenia. 9 Both thrombocytopenia and infection were somewhat more frequent in the more mature 35 þ weeks hospitalized infants compared to 30<35-week infants (Tables 1 and 2 ). This is likely explained by ascertainment bias, as only sick infants who are near term remain hospitalized in the NICU, while their healthier counterparts are quickly discharged. In contrast, even healthy infants from the less mature groups remain hospitalized for prolonged periods until mature oral-motor function, temperature and respiratory stability are achieved. Therefore, data from the less mature populations reflect a more complete spectrum of neonatal PLT counts. Circulating PLT concentrations are the net result of PLT production minus PLT consumption. Therefore, alternative hypotheses to explain neonatal thrombocytopenia contrast enhanced PLT consumption against insufficient PLT production. For example, prolonged indwelling catheters, respiratory distress, and mechanical ventilation can all increase PLT consumption. [22] [23] [24] [25] [26] [27] Figure 4 illustrates that thrombocytopenia is more persistent than generally recognized, particularly in the smallest infants. Noninfected, unventilated, AGA infants born at less than 27 weeks gestation exhibited prolonged risk of thrombocytopenia. In contrast, the noninfected PIH/SGA infants exhibited an early increased incidence of thrombocytopenia, which resolved quickly.
The mechanism of PIH-associated thrombocytopenia might involve decreased PLT production. Although not tested in this analysis, this assumption is based on the recognition that PIHassociated neutropenia is believed to be due to a placental factor that inhibits granulocyte production. 28 We can speculate that the absence of late thrombocytopenia in infants exposed to PIH might indicate that early thrombocytopenia triggered exuberant thrombopoiesis in these infants. A gestation-related insufficiency of thrombopoietin (TPO) regulation could explain protracted thrombocytopenia in AGA infants, and an unidentified maternal factor would explain the substantial increase in the thrombocytopenia in PIH-exposed infants. 29, 30 These hypotheses underscore the need for more direct measures distinguishing PLT synthesis from consumption in neonates. Quantification of reticulated PLTs as an index of neonatal thrombopoiesis may be one option. 31, 32 Evaluation of circulating TPO alone may have limited diagnostic value; 33 however, the combination of several approaches such as evaluation of plasma TPO, glycocalicin, and megakaryocyte cultures may help to distinguish mechanisms underlying neonatal thrombocytopenia. 34 Overall, thrombocytosis was common and, in noninfected AGA infants, it was more prevalent than thrombocytopenia, and varied inversely to postconceptional age, with a peak incidence at 35 weeks CGA. The average weekly PLT count and corresponding risk of thrombocytosis increased over time. These patterns collectively suggest the hypothesis that postnatal platelet regulation matures around 35 weeks CGA. Alternative explanations were considered. For example, anemia was associated with increased PLT counts; however, only 34% of the anemic infants had coincident thrombocytosis compared to 19% of infants with a normal HCT and coincident thrombocytosis. When anemia is factored out, the age-related patterns shown in Figure 2 are still true. Similarly, although reactive thrombocytosis may reduce mortality in neonates with infections, 35, 36 the 30<35-week infants in this analysis had comparatively few infections (Table 2a) thus disqualifying infection as a satisfactory explanation for the late-onset thrombocytosis.
In summary, these data associate postconceptional age with corresponding rates of thrombocytopenia and thrombocytosis in noninfected neonatal populations. The age-related PLT differences seen in this analysis may reflect the degree of maturation of thrombopoietic function in hospitalized neonates. This explanation would account for the lower PLT counts and persistently increased risk of thrombocytopenia in the <27-week infants, as well as the increased PLT counts and increased risk of thrombocytosis in the older infants. Collectively, this study highlights the importance of developing epidemiological data distinguishing the smallest or most premature neonates from other populations.
